Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

CESK1 Activators

CESK1, also known as C-terminal Src kinase homologous kinase, is a non-receptor tyrosine kinase encoded by the gene CSK homologous kinase (CHEK). This protein is a member of the C-terminal Src kinase (CSK) family and plays a significant role in the negative regulation of Src family kinases (SFKs), which are involved in various cellular processes, including proliferation, differentiation, and survival.CESK1 shares structural similarities with CSK, including the SH3, SH2, and kinase domains, which are crucial for its function. The SH3 and SH2 domains are responsible for protein-protein interactions, while the kinase domain mediates the phosphorylation of target proteins, typically on tyrosine residues. CESK1 is unique, however, in that it contains a longer C-terminal region compared to CSK, which may confer distinct regulatory properties upon the protein.

The primary function of CESK1 is to phosphorylate the C-terminal inhibitory tyrosine residue on SFKs. This phosphorylation leads to a conformational change in the SFKs, resulting in their inactivation. By controlling the activity of SFKs, CESK1 indirectly influences numerous signaling pathways that govern cellular function.Dysregulation of SFK activity can contribute to the development of cancer, and thus, CESK1, by modulating these kinases, is implicated in the suppression of oncogenic signaling. The activity of CESK1 itself is regulated by various mechanisms, including its own phosphorylation and protein-protein interactions, which modulate its localization and function within the cell.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

A Hsp90 inhibitor, could indirectly affect CCT8L2 by influencing protein folding pathways.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$67.00
$156.00
16
(2)

Another Hsp90 inhibitor, potentially impacting protein folding and stability, relevant to CCT8L2.

Radicicol

12772-57-5sc-200620
sc-200620A
1 mg
5 mg
$92.00
$333.00
13
(1)

Inhibits Hsp90, potentially affecting CCT8L2 activity in protein folding.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor, could indirectly affect protein turnover and folding processes involving CCT8L2.

Colchicine

64-86-8sc-203005
sc-203005A
sc-203005B
sc-203005C
sc-203005D
sc-203005E
1 g
5 g
50 g
100 g
500 g
1 kg
$100.00
$321.00
$2289.00
$4484.00
$18207.00
$34749.00
3
(2)

Disrupts microtubule polymerization, potentially affecting CCT8L2-related cytoskeletal proteins.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$41.00
$74.00
$221.00
$247.00
$738.00
$1220.00
39
(2)

Stabilizes microtubules, potentially influencing CCT8L2 activity in cytoskeletal dynamics.

Vinblastine

865-21-4sc-491749
sc-491749A
sc-491749B
sc-491749C
sc-491749D
10 mg
50 mg
100 mg
500 mg
1 g
$102.00
$235.00
$459.00
$1749.00
$2958.00
4
(0)

Inhibits microtubule formation, potentially impacting CCT8L2's function in protein folding.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Disrupts microtubule dynamics, which may indirectly affect CCT8L2 activity.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Activates adenylate cyclase, potentially influencing cellular processes relevant to CCT8L2.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Influences GSK-3 signaling, which could indirectly affect CCT8L2 in cellular processes.